Compare ABVX & DPZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | DPZ |
|---|---|---|
| Founded | 2013 | 1960 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Food Distributors |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 11.6B |
| IPO Year | 2022 | 2004 |
| Metric | ABVX | DPZ |
|---|---|---|
| Price | $114.64 | $342.63 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 24 |
| Target Price | $131.31 | ★ $434.29 |
| AVG Volume (30 Days) | ★ 801.6K | 766.4K |
| Earning Date | 03-23-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | N/A | ★ 5.27 |
| EPS | N/A | ★ 8.21 |
| Revenue | N/A | ★ $4,939,994,000.00 |
| Revenue This Year | $52.14 | $7.98 |
| Revenue Next Year | $4,132.27 | $3.97 |
| P/E Ratio | ★ N/A | $42.47 |
| Revenue Growth | N/A | ★ 4.96 |
| 52 Week Low | $69.81 | $282.00 |
| 52 Week High | $148.83 | $455.57 |
| Indicator | ABVX | DPZ |
|---|---|---|
| Relative Strength Index (RSI) | 43.49 | 54.02 |
| Support Level | $107.67 | $346.31 |
| Resistance Level | $129.00 | $351.96 |
| Average True Range (ATR) | 3.63 | 10.99 |
| MACD | -0.47 | -0.64 |
| Stochastic Oscillator | 35.04 | 79.03 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. The company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD. The Group operates in a single operating segment: R&D of pharmaceutical products in order to market them in the future.
Domino's is the world's largest pizza chain, surpassing $20 billion in system sales with over 22,100 stores across more than 90 markets at the end of 2025. Around 33% of its units are in the US. The business is 99% franchised. Domino's operates through three segments: supply chain (60% of revenue), US stores (33%), and international franchises (7%). The firm generates the bulk of its revenue by supplying food to stores in the US and Canada through a vertically integrated network of 25 manufacturing and supply chain facilities, which primarily produce and distribute dough, and collecting brand royalties and marketing fees from franchisees. Domino's also generates revenue from sales at company-owned stores.